Used in pharmaceutical research as a key intermediate for developing central nervous system (CNS) active compounds. It serves as a building block in the synthesis of selective receptor modulators, particularly targeting serotonin and dopamine receptors. Its structure supports the development of potential treatments for neurological disorders such as depression, anxiety, and schizophrenia. The compound's amide and piperidine moieties enhance binding affinity and selectivity, making it valuable in structure-activity relationship (SAR) studies. Also employed in the optimization of drug candidates for improved metabolic stability and blood-brain barrier penetration.